dPCR 和 qPCR 产品市场 - 全球产业规模、份额、趋势、机会和预测，按产品、应用、最终用户、地区和竞争格局划分，2020-2030 年预测

2024年全球数位PCR (dPCR) 和定量PCR (qPCR) 产品市场规模为82.4亿美元，预计到2030年将以7.39%的复合年增长率增长至126.4亿美元。数位聚合酶炼式反应 (dPCR) 和定量聚合酶炼式反应 (qPCR) 产品是用于精确检测和定量核酸的分子诊断工具。 qPCR 透过即时扩增进行相对或绝对定量，而 dPCR 则透过对样本进行分割进行绝对定量，从而提高对稀有标靶的灵敏度。市场成长的驱动因素包括全球传染病和遗传疾病盛行率的上升，以及不断提高检测效率的技术进步。即时诊断和个人化医疗的日益普及也推动了市场成长。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球数位PCR和定量PCR产品市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（试剂及耗材、仪器、软体）
  • 依应用领域（临床应用、法医应用）
  • 按最终使用者（医院和诊断中心、研究实验室和学术机构、临床研究机构、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美数位PCR和定量PCR产品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲数位PCR和定量PCR产品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区数位PCR和定量PCR产品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲数位PCR和定量PCR产品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲数位PCR和定量PCR产品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 最新进展
• 併购
• 产品发布

第十三章：全球数位PCR和定量PCR产品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton Dickinson and Company
• Bio Molecular Systems Pty Ltd.
• Biomeme Inc.
• Biomerieux SA
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company llc

第十六章：策略建议

第17章调查会社について・免责事项

The Global dPCR and qPCR Products Market , valued at USD 8.24 Billion in 2024, is projected to experience a CAGR of 7.39% to reach USD 12.64 Billion by 2030. Digital Polymerase Chain Reaction (dPCR) and quantitative Polymerase Chain Reaction (qPCR) products are molecular diagnostic tools for precise nucleic acid detection and quantification. qPCR measures real-time amplification for relative or absolute quantification, while dPCR segments samples for absolute quantification, enhancing sensitivity for scarce targets. Market growth is driven by the rising global prevalence of infectious diseases and genetic disorders, alongside continuous technological advancements improving assay efficiency. Increased adoption in point-of-care diagnostics and personalized medicine also provides momentum.

Key Market Drivers

The increasing global prevalence of infectious diseases and genetic disorders constitutes a primary driver for the dPCR and qPCR products market. These advanced molecular diagnostic tools offer the sensitivity and specificity required for early detection and accurate quantification of pathogens and genetic mutations, which is crucial for effective disease management and public health initiatives. For instance, according to the WHO Global Tuberculosis Report 2024, published on November 1, 2024, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, a notable increase from 7.5 million in 2022, highlighting the persistent and growing burden of infectious diseases that necessitate precise diagnostic solutions. Similarly, the expanding understanding of genetic predispositions and heritable conditions fuels the demand for high-resolution genetic analysis enabled by dPCR and qPCR.

Key Market Challenges

High capital expenditure associated with digital Polymerase Chain Reaction (dPCR) instrumentation and specialized reagents presents a significant impediment to the growth of the Global dPCR and qPCR Products Market. The substantial upfront investment required for advanced dPCR systems, coupled with the ongoing costs of specific reagents, creates a financial barrier for potential adopters. This directly constrains market expansion by limiting the accessibility of these technologies to a wider range of laboratories, especially smaller research facilities, clinical diagnostic centers with restricted budgets, and institutions in emerging economies.

Key Market Trends

The integration of AI and cloud-based data analytics is transforming PCR workflows, enhancing data processing, interpretation, and accessibility. AI algorithms provide more precise analysis of complex assay results, improving diagnostic accuracy and accelerating turnaround times. Cloud platforms offer scalable solutions for data storage and collaborative research, vital for managing increasing genomic data volumes. QIAGEN, for instance, announced in April 2025 its upcoming QIAsymphony Connect system will integrate digital connectivity and be compatible with QIAsphere, its cloud-based platform for remote monitoring. This market evolution towards sophisticated computational infrastructure is further evidenced by the Association for Molecular Pathology in May 2025, releasing three interrelated Body of Knowledge papers defining essential bioinformatics competencies for clinical diagnostic laboratories.

Key Market Players

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton Dickinson and Company
• Bio Molecular Systems Pty Ltd
• Biomeme Inc.
• Biomerieux S.A.
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company LLC

Report Scope:

In this report, the Global dPCR and qPCR Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

dPCR and qPCR Products Market , By Product:

dPCR and qPCR Products Market , By Application:

• Reagents & Consumables
• Instruments
• Software

dPCR and qPCR Products Market , By End User:

• Clinical Applications
• Forensic Applications

dPCR and qPCR Products Market , By Region:

• Hospitals & Diagnostic Centers
• Research Laboratories & Academic Institutes
• Clinical Research Organizations
• Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global dPCR and qPCR Products Market .

Available Customizations:

Global dPCR and qPCR Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global dPCR and qPCR Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Reagents & Consumables, Instruments, Software)
  • 5.2.2. By Application (Clinical Applications, Forensic Applications)
  • 5.2.3. By End User (Hospitals & Diagnostic Centres, Research Laboratories & Academic Institutes, Clinical Research Organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America dPCR and qPCR Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States dPCR and qPCR Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada dPCR and qPCR Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico dPCR and qPCR Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe dPCR and qPCR Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany dPCR and qPCR Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom dPCR and qPCR Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy dPCR and qPCR Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France dPCR and qPCR Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain dPCR and qPCR Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific dPCR and qPCR Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China dPCR and qPCR Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India dPCR and qPCR Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan dPCR and qPCR Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea dPCR and qPCR Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia dPCR and qPCR Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America dPCR and qPCR Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil dPCR and qPCR Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina dPCR and qPCR Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia dPCR and qPCR Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa dPCR and qPCR Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa dPCR and qPCR Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia dPCR and qPCR Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE dPCR and qPCR Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global dPCR and qPCR Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Agilent Technologies, Inc.
• 15.3. Analytik Jena AG
• 15.4. Becton Dickinson and Company
• 15.5. Bio Molecular Systems Pty Ltd.
• 15.6. Biomeme Inc.
• 15.7. Biomerieux S.A.
• 15.8. Bioneer Corporation
• 15.9. Bio-Rad Laboratories, Inc.
• 15.10. Cole-Parmer Instrument Company llc

16. Strategic Recommendations

17. About Us & Disclaimer